Achelios Therapeutics
Durham
About Achelios Therapeutics
Achelios Therapeutics is a pharmaceutical development company that focuses on advancing new product concepts through the 505(b)(2) process to early clinical proof of principle followed by asset (project) sale. Achelios has adopted a semi-virtual model to control costs and advance projects by utilizing its experienced team and on-call external pharmaceutical experts and partners. This allows the company’s management to precisely tailor project needs with the right level of expertise and/or key opinion leaders with influence at the FDA, academic medical centers, and at the level of the payer (insurance company/government).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.5M
- Last round: Debt Financing (Apr 2016)
- Website: achelios.com
- Phone: (919) 913-4605
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/achelios-therapeutics-170345 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.